Vaccine
17 videos · last 6 months shuffled daily, then older videos newest first
▶
8:03 Personalised Melanoma Vaccine Trial Results Explained
BBC News explains trial results showing a personalised vaccine given with an immunotherapy drug stopped melanoma returning, how personalised vaccines are made, their production challenges and when patients could get it.
▶
4:06 BBC North West News Report of the NEOVACC Clinical Trial at The Clatterbridge Cancer Centre
BBC North West News Health Correspondent Gill Dummigan reports on the NEOVACC clinical trial at Clatterbridge Cancer Centre - Liverpool. She interviews patient Chris Jones, the first person in the world to have this particular cancer vaccine for the most common lung cancer.
▶
25:28 Personalised Melanoma Vaccine and US mRNA Research Funding
BBC News speaks to Tom Whipple, host of BBC Inside Science, about a personalised mRNA vaccine that stopped melanoma returning in a trial, and how US cuts to mRNA vaccine research funding could affect health outcomes.
▶
10:02 Phase 3 Globo H Vaccine Trial in Triple-Negative Breast Cancer
Dr Hope Rugo tells ecancer about a phase 3 trial of adagloxad simolenin, a globo H-targeting cancer vaccine, with the adjuvant OBI-821 in high-risk early triple-negative breast cancer, stopped early for futility with no survival difference.
▶
2:10 Canada Approves Trial for mRNA Ebola Vaccine
CBC News on Health Canada approving a Phase 1 trial of Moderna's mRNA vaccine for the Bundibugyo strain of Ebola.
▶
3:31 BREAKTHROUGH: New Pancreatic Cancer Vaccine Shows Stunning Promise
Fox News on early results from an experimental pancreatic cancer vaccine, which produced a lasting immune response in most high-risk patients in the trial.
▶
4:20 HIV Vaccines at Night, Are Big and Bright, Deep in the Heart of Texas
A Texas physician, Dr. Barbara Taylor of University Health, discusses clinical trials of a HIV vaccine with a local news station.
▶
2:14 Mpox EMA Regulatory Pathway
GeoVax has received favourable scientific advice from the European Medicines Agency on GEO-MVA, supporting a streamlined route toward conditional approval of its mpox vaccine.
▶
1:31 Vaccines Sent to Uganda For Clinical Trials to Defeat Ebola
Oxford University and Pune Institute of India, Sabin Vaccine Institute and Merck provide vaccine candidates to Uganda for Ebola clinical trials to treat the Sudan strain of the virus.
▶
26:33 hVIVO's RSV-B Human Challenge Model
hVIVO Chief Scientific Officer Dr Andrew Catchpole describes the company's RSV human challenge model, including participant recruitment, clinical isolate selection and comparative RSV-B and RSV-A infection data.
▶
19:51 hVIVO's hMPV Human Challenge Model
hVIVO Chief Scientific Officer Dr Andrew Catchpole presents disease characteristics and immunological profiles from the company's new human metapneumovirus (hMPV) challenge model, now available for vaccine and antiviral trials.
▶
2:22 HIV Researchers at Scripps Search for a Vaccine Using Broadly Neutralizing Antibodies
HIV is a "hard target" for a vaccine, but Scripps Research is looking at ways to trigger "broadly neutralizing antibodies" to protect against contacting HIV. The "Scripps Antigen" elicited an immune response in 97% of patients, but these neutralizing antibodies are still "elusive" even after a clinical trial and so that is why Scripps is looking for a vaccine: to reduce infection from happening.
▶
3:24 VP of Clinical Operations on hLAB - Industry Leader in Virology & Immunology
hVIVO on hLAB, its virology, immunology and molecular laboratory services for drug and vaccine research.
▶
6:15 The mRNA Boom Is Upon Us and the University of Queensland Working on mRNA Vaccines
Video from ABC looks at how mRNA delivers genetic instructions and how these mRNA technologies started to gain traction with COVID so that now Australia has its own mRNA manufacturing plant and several pre-clinical advancements in mRNA delivery.
▶
4:19 MPOX Vaccine from Tonix Pharmaceuticals' Seth Lederman
Dr. Seth Lederman, Tonix Pharmaceuticals CEO and co-founder, discusses a new strain of more lethal mpox and potential vaccines.
▶
2:16 Fast Tracking a Game Changer in Addiction
A UW psychiatric researcher Marco Pravetoni, PhD discusses clinical trials and research involving a vaccine to treat all kinds of addiction.
▶
6:22 Texas Children's Patent-Free COVID Vaccine and Clinical Trials
NBC News shows two Texas physicians, Dr. Peter Hotez, MD, Ph.D. and Dr. Maria Elena Bottazzi, Ph.D, who created a vaccine using funds provided mostly by philanthropists that is free of any patent restrictions or requirements that manufacturers pay royalties to its creators.